B

Bangkok Genomics Innovation PCL
SET:BKGI

Watchlist Manager
Bangkok Genomics Innovation PCL
SET:BKGI
Watchlist
Price: 2.36 THB Market Closed
Market Cap: ฿1.4B

Wall St Price Targets

BKGI Price Targets Summary
Bangkok Genomics Innovation PCL

Wall Street analysts forecast BKGI stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BKGI is 1.73 THB with a low forecast of 1.72 THB and a high forecast of 1.79 THB.

Lowest Forecast
Price Target
1.72 THB
27% Downside
Average Forecast
Price Target
1.73 THB
27% Downside
Highest Forecast
Price Target
1.79 THB
24% Downside
Bangkok Genomics Innovation PCL Competitors:
Price Targets
VRTX
Vertex Pharmaceuticals Inc
3% Upside
LAND
Gladstone Land Corp
29% Upside

Revenue
Forecast

24% / Year
Past Growth
-6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
24% / Year
Past Growth
-6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 2 years is -6%.

Gross Profit
Forecast

16% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
16% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Gross Profit has been 16%.

Operating Income
Forecast

25% / Year
Past Growth
16% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
25% / Year
Past Growth
16% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 2 years is 16%.

Pre-Tax Income
Forecast

23% / Year
Past Growth
19% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
23% / Year
Past Growth
19% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 23%. The projected CAGR for the next 2 years is 19%.

Net Income
Forecast

18% / Year
Past Growth
23% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
18% / Year
Past Growth
23% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 2 years is 23%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is BKGI's stock price target?
Price Target
1.73 THB

According to Wall Street analysts, the average 1-year price target for BKGI is 1.73 THB with a low forecast of 1.72 THB and a high forecast of 1.79 THB.

What is the Revenue forecast for Bangkok Genomics Innovation PCL?
Projected CAGR
-6%

Over the last 2 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 2 years is -6%.

What is the Operating Income forecast for Bangkok Genomics Innovation PCL?
Projected CAGR
16%

Over the last 2 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 2 years is 16%.

What is the Pre-Tax Income forecast for Bangkok Genomics Innovation PCL?
Projected CAGR
19%

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 23%. The projected CAGR for the next 2 years is 19%.

What is the Net Income forecast for Bangkok Genomics Innovation PCL?
Projected CAGR
23%

Over the last 2 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next 2 years is 23%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett